In an escalation of the already heightened sentiments around threats of academic espionage, Moffitt Cancer Center said Alan List, its president and CEO, and center director Thomas Sellers have resigned for violating conflict of interest rules through their work in China. List and Sellers are the highest-ranking executives to be
This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking prescriptions, and appears to be…
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to help fortify the US supply of bird…
What’s left of Johnson & Johnson’s infectious disease work continues to shrink, after the company announced Friday that it had stopped work on a mid-stage…
This season’s uptake of RSV vaccines in the US has been slower than expected, according to Wall Street analysts tracking prescriptions, and appears to be…
GSK’s ViiV Healthcare has suspended development of a Phase 2-stage HIV antiviral named VH3739937, a GSK spokesperson confirmed to Endpoints News on Tuesday. The halt…
As the potential end of Robert Califf’s time as FDA commissioner nears, he and a key deputy are continuing to push forward with changes to…
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
While the worst of the funding slump for digital health startups since the lofty highs of the pandemic seems to be drawing to an end,…
The FDA on Thursday approved Bristol Myers Squibb’s new schizophrenia drug in one of the year’s most anticipated regulatory decisions. The approval gives Bristol Myers a…
SIGA Technologies said former chief medical officer Jay Varma’s comments about the company’s experimental mpox drug are
